American Cancer Society Releases New Colorectal Cancer Statistics; Rapid Shifts to More Advanced Disease and Younger People
Retrieved on:
Wednesday, March 1, 2023
Tissue, Alaska Natives, Colonoscopy, SEER, American Cancer Society Cancer Action Network, Surveillance, Cancer, Human, Diagnosis, Disease, Policy, ACS, Mortality, National Center for Health Statistics, North American Association of Central Cancer Registries, Colorectal cancer, Lymph, Health equity, National Cancer Institute, Research, Medical statistics, CMS, BBB National Programs, Meat, American Cancer Society, National Center for Complementary and Integrative Health, Medicare, CRC, Cost sharing, Large intestine, Centers for Medicare & Medicaid Services, Woman, Incidence, Dairy, Health insurance, Vaccine, Pharmaceutical industry, Epidemiology
ATLANTA, March 1, 2023 /PRNewswire/ -- Colorectal cancer is swiftly shifting to more advanced disease and younger individuals according to Colorectal Cancer Statistics 2023, a new report on cancer facts and trends by the American Cancer Society (ACS).
Key Points:
- ATLANTA, March 1, 2023 /PRNewswire/ -- Colorectal cancer is swiftly shifting to more advanced disease and younger individuals according to Colorectal Cancer Statistics 2023, a new report on cancer facts and trends by the American Cancer Society (ACS).
- Overall, in 2023, an estimated 153,020 people will be diagnosed with CRC in the U.S., and 52,550 people will die from the disease.
- These major findings are to be published today in CA: A Cancer Journal for Clinicians , alongside its consumer-friendly companion, Colorectal Cancer Facts & Figures 2023-2025, available on cancer.org .
- "These highly concerning data illustrate the urgent need to invest in targeted cancer research studies dedicated to understanding and preventing early-onset colorectal cancer," said Dr. Karen E. Knudsen , CEO of the American Cancer Society.